Century Therapeutics, Inc.
IPSC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850119
In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Century Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 64 | 55 | −9 |
| Shares | 19.3M | 18.1M | −1.23M (−6.4%) |
| Value | $61.0M | $36.1M | −$24.8M (−40.7%) |
New holders (4)
Institutions that held Century Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wealth Enhancement Advisory Services, LLC | 30,151 | $60.3K | 0.00% |
| SG Americas Securities, LLC | 10,340 | $21.0K | 0.00% |
| Comerica Bank | 4,221 | $8.44K | 0.00% |
| CWM, LLC | 45 | $0 | 0.00% |
Sold out (13)
Institutions that held Century Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Millennium Management LLC | 56,009 | $177.0K |
| Martingale Asset Management L P | 49,151 | $155.3K |
| Trexquant Investment LP | 32,630 | $103.1K |
| Man Group plc | 25,011 | $79.0K |
| State of Wisconsin Investment Board | 22,500 | $71.1K |
| Gsa Capital Partners LLP | 20,472 | $65.0K |
| Two Sigma Investments, LP | 15,864 | $50.1K |
| Two Sigma Advisers, LP | 15,600 | $49.3K |
| Franklin Resources Inc | 12,516 | $39.6K |
| Mirae Asset Global Investments Co., Ltd. | 12,477 | $39.4K |
| Nisa Investment Advisors, LLC | 5,941 | $18.8K |
| Lazard Asset Management LLC | 930 | $2.00K |
| Simplex Trading, LLC | 116 | $0 |